Suppr超能文献

通过全基因组测序确定凝固酶阴性葡萄球菌对利奈唑胺耐药的机制。

Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing.

作者信息

Tewhey Ryan, Gu Bing, Kelesidis Theodoros, Charlton Carmen, Bobenchik April, Hindler Janet, Schork Nicholas J, Humphries Romney M

机构信息

Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

UCLA David Geffen School of Medicine, Division of Infectious Diseases, Los Angeles, California, USA.

出版信息

mBio. 2014 May 13;5(3):e00894-14. doi: 10.1128/mBio.00894-14.

Abstract

UNLABELLED

Linezolid resistance is uncommon among staphylococci, but approximately 2% of clinical isolates of coagulase-negative staphylococci (CoNS) may exhibit resistance to linezolid (MIC, ≥8 µg/ml). We performed whole-genome sequencing (WGS) to characterize the resistance mechanisms and genetic backgrounds of 28 linezolid-resistant CoNS (21 Staphylococcus epidermidis isolates and 7 Staphylococcus haemolyticus isolates) obtained from blood cultures at a large teaching health system in California between 2007 and 2012. The following well-characterized mutations associated with linezolid resistance were identified in the 23S rRNA: G2576U, G2447U, and U2504A, along with the mutation C2534U. Mutations in the L3 and L4 riboproteins, at sites previously associated with linezolid resistance, were also identified in 20 isolates. The majority of isolates harbored more than one mutation in the 23S rRNA and L3 and L4 genes. In addition, the cfr methylase gene was found in almost half (48%) of S. epidermidis isolates. cfr had been only rarely identified in staphylococci in the United States prior to this study. Isolates of the same sequence type were identified with unique mutations associated with linezolid resistance, suggesting independent acquisition of linezolid resistance in each isolate.

IMPORTANCE

Linezolid is one of a limited number of antimicrobials available to treat drug-resistant Gram-positive bacteria, but resistance has begun to emerge. We evaluated the genomes of 28 linezolid-resistant staphylococci isolated from patients. Multiple mutations in the rRNA and associated proteins previously associated with linezolid resistance were found in the isolates investigated, underscoring the multifocal nature of resistance to linezolid in Staphylococcus. Importantly, almost half the S. epidermidis isolates studied harbored a plasmid-borne cfr RNA methylase gene, suggesting that the incidence of cfr may be higher in the United States than previously documented. This finding has important implications for infection control practices in the United States. Further, cfr is commonly detected in bacteria isolated from livestock, where the use of phenicols, lincosamides, and pleuromutilins in veterinary medicine may provide selective pressure and lead to maintenance of this gene in animal bacteria.

摘要

未标注

利奈唑胺耐药在葡萄球菌中并不常见,但约2%的凝固酶阴性葡萄球菌(CoNS)临床分离株可能对利奈唑胺耐药(最低抑菌浓度≥8μg/ml)。我们进行了全基因组测序(WGS),以表征2007年至2012年间从加利福尼亚州一个大型教学卫生系统的血培养中获得的28株耐利奈唑胺CoNS(21株表皮葡萄球菌分离株和7株溶血葡萄球菌分离株)的耐药机制和遗传背景。在23S rRNA中鉴定出以下与利奈唑胺耐药相关的特征性突变:G2576U、G2447U和U2504A,以及C2534U突变。在20株分离株中还鉴定出L3和L4核糖体蛋白中先前与利奈唑胺耐药相关位点的突变。大多数分离株在23S rRNA以及L3和L4基因中存在不止一个突变。此外,在近一半(48%)的表皮葡萄球菌分离株中发现了cfr甲基化酶基因。在本研究之前在美国葡萄球菌中很少鉴定到cfr。鉴定出相同序列类型的分离株具有与利奈唑胺耐药相关的独特突变,表明每个分离株中利奈唑胺耐药是独立获得的。

重要性

利奈唑胺是可用于治疗耐药革兰氏阳性菌的少数抗菌药物之一,但耐药性已开始出现。我们评估了从患者分离出的28株耐利奈唑胺葡萄球菌的基因组。在所研究的分离株中发现了rRNA及先前与利奈唑胺耐药相关蛋白的多个突变,强调了葡萄球菌对利奈唑胺耐药的多灶性本质。重要的是,近一半所研究的表皮葡萄球菌分离株携带质粒介导的cfr RNA甲基化酶基因,这表明在美国cfr的发生率可能高于先前记录。这一发现对美国的感染控制措施具有重要意义。此外,在从家畜分离出的细菌中普遍检测到cfr,在兽医学中使用酚类、林可酰胺类和截短侧耳素类药物可能提供选择压力并导致该基因在动物细菌中维持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/938d/4030478/7b06e6515eaa/mbo0021418130001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验